University of Maryland School of Pharmacy, Department of Pharmaceutical Health Services Research

Using a strategic framework, I led an initiative to evaluate, design, and facilitate large scale heterogenous data linkages with SEER cancer registry data. Novel linkages enhance the availability of longitudinal treatment-related data by elucidating key components of the patient trajectory to better understand individual patient and population level health outcomes. I was responsible for developing collaborative partnerships across several federal agencies (current scientific collaborations with the VA, CDC, FDA, and DOE),as well as academic institutions and commercial entities to advance precision cancer surveillance. Within the current portfolio I managed partnerships with a myriad of clinical health data vendors across 12 clinical data types.Real World Evidence: Leading novel data collaborations, linkages, and analytic strategy within SEER to enhance data for precision cancer surveillance. Pharmacy Data Expertise: Global picture of medication utilization within the healthcare system for data acquisition and longitudinal treatment evaluation. Cancer Pharmacoepidemiology: Evaluating oncology medication utilization and outcomes using SEER and SEER-Medicare data.Research tools to standardize observational research include serving as the Clinical Developer of the Cancer Medication Enquiry Database (CanMED): https://seer.cancer.gov/oncologytoolbox/Fellowship Director, Pharmacy Fellowship in Cancer Surveillance and Clinical Data Science: https://surveillance.cancer.gov/jobs/pharmacy.html

Individualized training as clinician epidemiologist with leadership on pharmacoepidemiology studies and pharmacogenetic survey development to advance cancer control and population sciences methods.

PHA 5226 Evidence-Based PharmacyCourse Facilitator (2013), TA (2012)PHA 5742C Professional Communication in PharmacyLead TA (2014), TA (2013)Delivered the weekly course lectures and recorded lectures for distance studentsCreated presentations and educational materials for teachingPlanning and curriculum development with TAs and facultyGraded projects and assignments and provided productive feedback (150+ students)

Clinical trial protocol and study document developmentDeveloped a Phase I Clinical Trial Protocol Integrated PK data into clinical softwareDevelop FDA submission documents (e.g. IND, aNDA)Organized weekly team meetings to ensure a successful preclinical development planLiaison between clinical trial center and GSKInteracted with required contributors to the drug development process in industry including regulatory, formulation, and value teams